Abstract:Proteolysis-targeting chimeras (PROTACs) are hetero-bifunctional molecules. They induce the degradation of a target protein by recruiting an E3 ligase to the target. The PROTAC can inactivate disease-related genes that are considered as understudied, thus has a great potential to be a new type of therapy for the treatment of incurable diseases. However, only hundreds of proteins have been experimentally tested if they are amenable to the PROTACs. It remains elusive what other proteins can be targeted by the PROTAC in the entire human genome. For the first time, we have developed an interpretable machine learning model PrePROTAC, which is based on a transformer-based protein sequence descriptor and random forest classification to predict genome-wide PROTAC-induced targets degradable by CRBN, one of the E3 ligases. In the benchmark studies, PrePROTAC achieved ROC-AUC of 0.81, PR-AUC of 0.84, and over 40% sensitivity at a false positive rate of 0.05, respectively. Furthermore, we developed an embedding SHapley Additive exPlanations (eSHAP) method to identify positions in the protein structure, which play key roles in the PROTAC activity. The key residues identified were consistent with our existing knowledge. We applied PrePROTAC to identify more than 600 novel understudied proteins that are potentially degradable by CRBN, and proposed PROTAC compounds for three novel drug targets associated with Alzheimer's disease. Author summary: Many human diseases remain incurable because disease-causing genes cannot by selectively and effectively targeted by small molecules. Proteolysis-targeting chimera (PROTAC), an organic compound that binds to both a target and a degradation-mediating E3 ligase, has emerged as a promising approach to selectively target disease-driving genes that are not druggable by small molecules. Nevertheless, not all of proteins can be accommodated by E3 ligases, and be effectively degraded. Knowledge on the degradability of a protein will be crucial for the design of PROTACs. However, only hundreds of proteins have been experimentally tested if they are amenable to the PROTACs. It remains elusive what other proteins can be targeted by the PROTAC in the entire human genome. In this paper, we propose an intepretable machine learning model PrePROTAC that takes advantage of powerful protein language modeling. PrePROTAC achieves high accuracy when evaluated by an external dataset which comes from different gene families from the proteins in the training data, suggesting the generalizability of PrePROTAC. We apply PrePROTAC to the human genome, and identify more than 600 understudied proteins that are potentially responsive to the PROTAC. Furthermore, we design three PROTAC compounds for novel drug targets associated with Alzheimer's disease.

Long-term Proposal Report Structural Study of Regulated Intramembrane Proteolysis

[Research Progress on Receptor Interacting Proteins in Inflammation].

Structure of a Presenilin Family Intramembrane Aspartate Protease

Lipid environment modulates processivity and kinetics of a presenilin homolog acting on multiple substrates in vitro

Active site geometry stabilization of a presenilin homolog by the lipid bilayer promotes intramembrane proteolysis

Therapeutic Potential of Targeting Regulated Intramembrane Proteolysis Mechanisms of Voltage-Gated Ion Channel Subunits and Cell Adhesion Molecules

The structure of mouse RIPK1 RHIM-containing domain as a homo-amyloid and in RIPK1/RIPK3 complex

Protein Disulfide Isomerase Regulates Endoplasmic Reticulum Stress and the Apoptotic Process During Prion Infection and Prp Mutant-Induced Cytotoxicity

Structural Analysis of a Rhomboid Family Intramembrane Protease Reveals a Gating Mechanism for Substrate Entry

Membrane cholesterol as regulator of human rhomboid protease RHBDL4

Mechanism Study of Proteins under Membrane Environment

Structural Study of MCPIP1 N-terminal Conserved Domain Reveals a PIN-like RNase

A conserved structural determinant located at the interdomain region of mammalian inositol-requiring enzyme 1alpha.

An in vitro platform for the enzymatic characterization of the rhomboid protease RHBDL4

Structure of a Site-2 Protease Family Intramembrane Metalloprotease.

A Conserved Structural Determinant Located at the Interdomain Region of Mammalian IRE1α

Structural Insights into RIP3-Mediated Necroptotic Signaling

Lipid-polymer nanoparticles to probe the native-like environment of intramembrane rhomboid protease GlpG and its activity

The structure of a minimum amyloid fibril core formed by necroptosis-mediating RHIM of human RIPK3

Heme binding of transmembrane signaling proteins undergoing regulated intramembrane proteolysis

Elucidation of Genome-wide Understudied Proteins targeted by PROTAC-induced degradation using Interpretable Machine Learning